IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer - intervention trial 2. Study protocol

Acta Oncol. 2020 Mar;59(3):336-341. doi: 10.1080/0284186X.2019.1711170. Epub 2020 Jan 10.

Authors

Jesper Nors^{1

2}, Tenna Vesterman Henriksen¹, Kåre Andersson Gotschalck², Therese Juul^{3

4}, Jes Søgaard⁵, Lene Hjerrild Iversen³, Claus Lindbjerg Andersen¹

Affiliations

¹ Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
² Department of Surgery, Randers Regional Hospital, Randers, Denmark.
³ Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
⁵ Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

PMID: 31920137
DOI: 10.1080/0284186X.2019.1711170

No abstract available

Publication types

Letter
Multicenter Study
Randomized Controlled Trial

MeSH terms

Circulating Tumor DNA / analysis*
Circulating Tumor DNA / genetics
Colorectal Neoplasms / genetics
Colorectal Neoplasms / pathology
Colorectal Neoplasms / surgery*
Colorectal Surgery / standards*
Follow-Up Studies
Humans
Postoperative Period
Prognosis

Substances

Circulating Tumor DNA